5 research outputs found

    Reactive SPS of Al2O3–RE:YAG (RE = Ce; Ce+Gd) composite ceramic phosphors

    Get PDF
    Ultrafine-grained Al2O3–rare earth:yttrium aluminium garnet (Al2O3–RE:YAG) (RE = Ce; Ce+Gd) composite ceramics were obtained for the first time by reactive spark plasma sintering (SPS) using commercially available initial oxide powders. The effect of key sintering parameters (temperature, dwell time, and external pressure (Pload)) on densification peculiarities, structural-phase states, and luminescent properties of composites was studied comprehensively. Differences in phase formation and densification between Ce-doped and Ce,Gd-codoped systems were shown. Parameters of reactive SPS, at which there is partial melting with the formation of near-eutectic zones of the Al2O3–YAG system/coexistence of several variations of the YAG-type phase, were established. Pure corundum–garnet biphasic ceramics with an optimal balance between microstructural and luminescence performance were synthesized at 1425 ℃/30 min/30–60 MPa. The external quantum efficiency (EQE) of the phosphor converters reached 80.7% and 72% with close lifetime of ~63.8 ns, similar to those of commercial Ce:YAG materials, which is promising for further applications in the field of high-power white light-emitting diodes (WLEDs) and laser diodes (LDs)

    Influence of Surface Ligand Density and Particle Size on the Penetration of the Blood–Brain Barrier by Porous Silicon Nanoparticles

    No full text
    Overcoming the blood–brain barrier (BBB) remains a significant challenge with regard to drug delivery to the brain. By incorporating targeting ligands, and by carefully adjusting particle sizes, nanocarriers can be customized to improve drug delivery. Among these targeting ligands, transferrin stands out due to the high expression level of its receptor (i.e., transferrin receptor) on the BBB. Porous silicon nanoparticles (pSiNPs) are a promising drug nanocarrier to the brain due to their biodegradability, biocompatibility, and exceptional drug-loading capacity. However, an in-depth understanding of the optimal nanoparticle size and transferrin surface density, in order to maximize BBB penetration, is still lacking. To address this gap, a diverse library of pSiNPs was synthesized using bifunctional poly(ethylene glycol) linkers with methoxy or/and carboxyl terminal groups. These variations allowed us to explore different transferrin surface densities in addition to particle sizes. The effects of these parameters on the cellular association, uptake, and transcytosis in immortalized human brain microvascular endothelial cells (hCMEC/D3) were investigated using multiple in vitro systems of increasing degrees of complexity. These systems included the following: a 2D cell culture, a static Transwell model, and a dynamic BBB-on-a-chip model. Our results revealed the significant impact of both the ligand surface density and size of pSiNPs on their ability to penetrate the BBB, wherein intermediate-level transferrin densities and smaller pSiNPs exhibited the highest BBB transportation efficiency in vitro. Moreover, notable discrepancies emerged between the tested in vitro assays, further emphasizing the necessity of using more physiologically relevant assays, such as a microfluidic BBB-on-a-chip model, for nanocarrier testing and evaluation
    corecore